In contrast, dupilumab, a monoclonal antibody that targets the IL-4R alpha chain common to both the IL-4 and IL-13 receptors, prevents transduction signals stimulated by IL-4 and IL-13, and has been utilized for asthma treatment. Here, IL13 is linked to asthma.